UOC
PEPLW

UBS O'Connor’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

UBS O'Connor’s Portfolio PEPLW Stock Details PEPLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-73,355
Closed -$7.15K – 673
2023
Q1 		$7.15K Buy
+73,355
New +$6.16K ﹤0.01% 605
2022
Q4 		– Sell
-73,355
Closed -$5K – 494
2022
Q3 		$5K Sell
73,355
-7,343
-9% -$1.06K ﹤0.01% 938
2022
Q2 		$17K Buy
+80,698
New +$33K ﹤0.01% 919
2022
Q1 		– Sell
-128,942
Closed -$68K – 352
2021
Q4 		$68K Buy
+128,942
New +$60.9K ﹤0.01% 884

Other funds holding PEPLW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

UBS O'Connor's PEPLW Position: Q2 2023 in Review

UBS O'Connor sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q2 2023, closing a stake of 73,355 shares — an estimated $7.15K sold.

UBS O'Connor first reported a position in PEPLW in Q4 2021 and held it in 4 quarters. The position peaked at $68K in Q4 2021. 16 funds tracked by Wall St. Rank hold PEPLW as of Q2 2023.

  • UBS O'Connor reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q2 2023 after selling out during the quarter.
  • UBS O'Connor sold 73,355 PepperLime Health Acquisition Corporation Warrrant shares in Q2 2023, an estimated $7.15K.
  • UBS O'Connor first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 4 quarters.
  • UBS O'Connor's PepperLime Health Acquisition Corporation Warrrant position peaked at $68K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q2 2023.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.